<DOC>
	<DOCNO>NCT00573716</DOCNO>
	<brief_summary>This study examine use antipsychotic medication might contribute interruption bone mineral development and/or reduction bone mineral content adolescent .</brief_summary>
	<brief_title>Comparison Bone Mineral Density Changes During Tx With Risperidone Aripiprazole Adolescents</brief_title>
	<detailed_description>Studies show antipsychotic medication , include Risperdal , increase prolactin level adult pediatric population . Prolactin hormone make central nervous system . The main function prolactin regulate lactation female . However , much prolactin time interrupt bone mineral accrual decrease bone density . Since peak bone mass reach adolescent , key determinant lifetime risk osteoporosis . On hand , ahve report increase prolactin use Abilify . In fact , adult Abilify show normalize even low prolactin level . In study , compare amount prolactin bone mineral density adolescent take Risperdal Abilify bone mineral density adolescents nto take antipsychotic medication . We also compare amount prolactin bone mineral density adolescent take Risperdal take Abilify . This study also help u learn relationship medication , prolactin level , sex steroid , bone formation marker adolescent .</detailed_description>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Between age 11 17 year Females male aripiprazole risperidone monotherapy minimum one year Within 10th 90th percentile height weight Pregnancy Chronic illness asthma , inflammatory bowel disease , rheumatoid disorder cystic fibrosis , chronic systemic steroid therapy past 12 month Menstrual irregularity secondary excessive physical activity History anorexia nervosa and/or bulimia nervosa Subjects hormonal contraception</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>bone mineral content</keyword>
	<keyword>aripiprazole monotherapy</keyword>
	<keyword>risperidone monotherapy</keyword>
</DOC>